I take ER calls as a plastic surgeon. The ER doctor performs the primary repair on cases for which they determine don’t warrant calling me and tells the patients to see me for follow-up. If the patient never calls, am I liable...
Read MoreI take ER calls as a plastic surgeon. The ER doctor performs the primary repair on cases for which they determine don’t warrant calling me and tells the patients to see me for follow-up. If the patient never calls, am I liable...
Read MoreThe results of CONTESSA, a Phase 3 study of tesetaxel in the treatment of patients with metastatic breast cancer, have been selected for an oral presentation at the 2020 SABCS, to be held virtually December 8-11, 2020. The...
Read MoreHomologous recombination deficiency represents a new therapeutic strategy for breast cancer brain metastases Nicola S Cosgrove BACKGROUND: Brain metastatic disease occurs in 10-30% of metastatic breast cancer cases. The...
Read MoreThe collaborative Phase 3 PENELOPE-B will be presented at SABCS 2020. No unexpected safety signals were observed. Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free survival (iDFS) in...
Read MoreNew Data for HER2 and HER3 Directed DXd ADCs at SABCS includes longer follow-up research data for ENHERTU® based on DESTINY-Breast01, including updated duration of response, progression-free survival, an 18-month landmark...
Read MoreThe 43rd Virtual San Antonio Breast Cancer Symposium (SABCS®) will take place from December 8-11, 2020. The SABCS is the premier conference for basic, translational, and clinical cancer research professionals. It is well-known...
Read MoreTwo complimentary papers presented at the American Heart Association Scientific Sessions 2020 Virtual meeting, and published back to back in the Lancet [1,2], showed strong evidence that individuals aged over 70 years benefit at...
Read More
“Ye are not having a heart attack. Ye just ate too much turkey.”
Read MoreThe orally available, selective tyrosine kinase-2 inhibitor deucravacitinib met the primary and all secondary endpoints and improved quality of life in a randomized, double-blind, placebo-controlled phase 2 trial that included...
Read MoreA large international survey showed that only few children with rheumatic diseases contracted COVID-19. None of these children required hospitalization or had severe disease outcomes, despite the intake of immunosuppressive...
Read MoreStudies confirm improvement achieved and maintained through one year of active treatment with similar scores for patients switching from placebo to guselkumab Guselkumab is the first and only U.S. FDA-approved selective...
Read MoreCOVID-19 and Patients with Rheumatic Disease on Biologic & Targeted Therapies : A Systematic Review Information about the outcomes of patients with rheumatic disease with SARS-CoV-2 infection is scarce. Patients with...
Read MoreIn order assess the time to corneal epithelization with photoactivated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL) as a first-line treatment for early infectious corneal ulcers and to compare PACK-CXL...
Read MoreStudy results have long shown that miotics can help improve near vision by contracting the iris sphincter, thus reducing pupil size. Mild contraction of the ciliary muscle with some agents, including pilocarpine, may also...
Read MoreIn order to understand the outcomes of a teleophtalmology intitiative implemented at the Columbia University Irving Medical Center during the COVID-19 pandemic, researchers analyzed the number of patients requiring in-office...
Read MoreAt the European Society for Medical Oncology (ESMO) Virtual Congress 2020 , lead study investigator Prof. Byoung Chul Cho (Yonsei Cancer Centre, Yonsei University College of Medicine in Seoul, South Korea) presented the interim...
Read More
Research indicates that, with shared risk factors, hepatitis C virus (HCV) and hepatitis B virus...
Read More
MONDAY, Sept. 14, 2020 (HealthDay News) — From 2011 to 2017, there was an increase in the...
Read More
Meaningful Use was a vision for EMRs that in many ways turned out to be a joke. Consider my list...
Read More
